The Latest in Critical Care, 9/28/23 (Issue #15)
Systemic corticosteroids (such as intravenous dexamethasone) improve outcomes in severe pneumonia due to SARS-CoV-2 infection. It makes sense that inhaled steroids might improve outcomes from less severe infections. Do they?
In the STOIC trial (a phase 2, open-label, randomized trial), 146 outpatients in the U.…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.